Researchers discovered Fyn enzyme clusters when immobilized in synapses, forming toxic 'protein clumps' linked to dementia. Targeting Tau biomolecular condensates may prevent dementia progression.
A new study has shown that bivalirudin is a safer and more effective anticoagulant than heparin for treating heart attack patients. The trial found that bivalirudin significantly reduced death, major bleeding, and thrombosis in patients undergoing percutaneous coronary intervention.
A randomized study compared the effects of torsemide and furosemide in people with heart failure. The study found that both loop diuretics were effective in reducing death and hospitalization rates, with no significant clinical difference between the two medications.
A new study by Intermountain Healthcare found that following up a cardiac event with a statin prescription and cholesterol measuring blood test prevents 94% of patients from having or dying from a second cardiovascular event. Patients without follow-up care were at a 60% risk, compared to just 6% for those who received treatment.
Researchers have discovered a new gene, Schlafen11 (SLFN11), which correlates with chemotherapy response in medulloblastoma. The study's findings suggest SLFN11 can help improve treatment outcomes by increasing sensitivity to cisplatin.
Researchers at Intermountain Healthcare found that taking selective serotonin reuptake inhibitors (SSRIs) does not reduce the severity of COVID-19 illness or death. Not being on an SSRI was associated with a lower risk of hospitalization and death from COVID.
A clinical trial found that early use of ECMO devices did not improve outcomes for adults with rapidly deteriorating or severe cardiogenic shock. Participants who received immediate ECMO therapy showed similar clinical outcomes as those receiving early conservative therapy, including treatment with inotropes and vasopressors.
Researchers found that combining CAP and PAW leads to a synergistic effect, increasing fungicidal efficiency. The mechanism involves damage to cell wall and membrane structure via ·OH and O2, followed by irreversible damage to mitochondria with ONOO- entry.
A new AI technology has been developed to automatically diagnose lung diseases such as tuberculosis and pneumonia, freeing up radiographers and reducing waiting times for test results. The system, which uses X-ray imaging and deep learning algorithms, achieved a 98% accuracy rate during extensive testing.
Researchers evaluated the safety and efficacy of NTLA-2001 in patients with transthyretin amyloid cardiomyopathy. The results showed significant reductions in circulating TTR protein levels, which were sustained for up to six months after treatment.
Researchers at Intermountain Healthcare discovered that patients without standard modifiable heart risk factors who experience a heart attack fare better, with lower rates of revascularization procedures and subsequent major cardiac events. This finding highlights the need to identify patients at risk for an event before it happens.
A customized mindfulness program that incorporates skills like attention control and self-awareness has been shown to lead to lower systolic blood pressure measures in participants. The intervention, which also focuses on health behavior change, is promising as a novel way to improve blood pressure control.
The study presents UnityMol as a successful software tool for VR porting, enabling enhanced digital twin models. Interactive simulations also have great potential for research and collaborative problem-solving.
A new study has shown that SGLT-2 inhibitors, a type of diabetes medication, can decrease cardiovascular risk in adults with chronic kidney disease. The meta-analysis included results from 13 major clinical trials and found a 28% lower risk of worsening kidney disease and death from cardiovascular disease.
A large clinical trial found that administering steroids during infant heart surgery did not improve post-operative outcomes compared to placebo. However, secondary analysis revealed a small net benefit for some infants, with lower odds of bleeding requiring another operation.
The study proposes a balanced-partitioning treemapping method that maintains near-square aspect ratios for better small element visibility. It also creates stable layouts for time-dependent sequences, such as stock market variation with time.
Researchers at Brigham and Women's Hospital found that olpasiran, a small interfering RNA drug, significantly reduces lipoprotein(a) levels in patients with established cardiovascular disease. The treatment was associated with minimal serious side effects apart from injection site reactions.
A new study found that long-term treatment with intravenous iron improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency. The treatment was associated with a significant benefit on reducing the risk of heart failure hospitalization and cardiovascular death.
A study published in the American Heart Association found that six common dietary supplements did not lower LDL cholesterol levels when compared to a low-dose statin medication or placebo. The research suggests that these supplements are unlikely to offer meaningful impact on cholesterol levels, and a heart-healthy lifestyle is still t...
The discussion focused on the impact of ocean acidification, compound events, sea-level rise, and climate injustice, with experts highlighting the need for youth involvement in decision-making. The panel agreed on the urgent need for climate action ahead of COP27, emphasizing cooperation between nations to mitigate the crisis.
Researchers developed a simulation software to study radiation damage accumulation mechanisms in nanocrystalline materials. The results showed improved radiation resistance due to high grain boundary density, which serves as sinks for radiation-induced vacancies and self-interstitial atoms.
A new medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes, but did not decrease their cardiovascular risk. The study found that lowering triglyceride levels may not protect against cardiovascular disease in people with Type 2 diabetes.
Researchers at Hefei Institutes of Physical Science, Chinese Academy of Sciences, have discovered a potent and selective colony stimulating factor 1 receptor kinase inhibitor. The new compound, IHMT-CSF1R-833, shows high selectivity over human kinases and suppresses tumor-associated macrophage survival and activation.
Patients who survived cardiac arrest and received CPR reported lucid experiences of death, including separation from the body and meaningful evaluation of life. Researchers discovered rhythmic brain waves suggestive of near-death experiences, providing evidence for a unique human experience on the brink of death.
Researchers found that two common diuretics, chlorthalidone and hydrochlorothiazide, had no difference in cardiovascular outcomes among study participants. However, those taking chlorthalidone showed a reduced risk of heart disease and death by an average of 27% among patients with a history of heart attack or stroke.